ConductScience.org, home

Paper7697276

Parenteral application of a Pseudomonas aeruginosa flagella vaccine elicits specific anti-flagella antibodies in the airways of healthy individuals.

Döring G and 4 others. Am J Respir Crit Care Med, 1995. Cited by 38 papers, by iCite.

Cite this record

ConductScience Library. Parenteral application of a Pseudomonas aeruginosa flagella vaccine elicits specific anti-flagella antibodies in the airways of healthy individuals. Papers, record 7697276. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7697276

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Parenteral application of a Pseudomonas aeruginosa flagella vaccine elicits specific anti-flagella antibodies in the airways of healthy individuals.
PubMed
Journal
Am J Respir Crit Care Med
PubMed
Year
1995
PubMed
Publication types
Clinical Trial, Clinical Trial, Phase II, Journal Article
PubMed
Citations, by iCite
38
iCite
Relative citation ratio, by iCite
1.16
iCite
Revised in PubMed
2019-11-05
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Döring GG
2Pfeiffer CC
3Weber UU
4Mohr-Pennert AA
5Dorner FF

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antibodies, BacterialMajor topic
Bacterial VaccinesMajor topic
Bronchoalveolar Lavage FluidMajor topic
Pseudomonas aeruginosaMajor topic
Adult
Humans
Vaccination

Source PubMed

Download CSV of topics

Cited by14

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 38 citations.

PMIDTitleJournalYearIn PapersSource
40076637Pseudomonas aeruginosa Vaccine Development: Lessons, Challenges, and Future Innovations.Int J Mol Sci2025https://conductscience.org/library/papers/40076637PubMed
36258073Flagella, Chemotaxis and Surface Sensing.Adv Exp Med Biol2022https://conductscience.org/library/papers/36258073PubMed
35891262Pseudomonas aeruginosa: Recent Advances in Vaccine Development.Vaccines (Basel)2022https://conductscience.org/library/papers/35891262PubMed
34602924The impact of human vaccines on bacterial antimicrobial resistance. A review.Environ Chem Lett2021https://conductscience.org/library/papers/34602924PubMed
33291484Understanding Pseudomonas aeruginosa-Host Interactions: The Ongoing Quest for an Efficacious Vaccine.Cells2020https://conductscience.org/library/papers/33291484PubMed
33199354Defining the Mechanistic Correlates of Protection Conferred by Whole-Cell Vaccination against Pseudomonas aeruginosa Acute Murine Pneumonia.Infect Immun2021https://conductscience.org/library/papers/33199354PubMed
30188914Development of a broad spectrum glycoconjugate vaccine to prevent wound and disseminated infections with Klebsiella pneumoniae and Pseudomonas aeruginosa.PLoS One2018https://conductscience.org/library/papers/30188914PubMed
26618824Vaccine strategies against cystic fibrosis pathogens.Hum Vaccin Immunother2016https://conductscience.org/library/papers/26618824PubMed
22734046Identification of broadly protective human antibodies to Pseudomonas aeruginosa exopolysaccharide Psl by phenotypic screening.J Exp Med2012https://conductscience.org/library/papers/22734046PubMed
21941090Recent developments for Pseudomonas vaccines.Hum Vaccin2011https://conductscience.org/library/papers/21941090PubMed
17683588Assessment of pulmonary antibodies with induced sputum and bronchoalveolar lavage induced by nasal vaccination against Pseudomonas aeruginosa: a clinical phase I/II study.Respir Res2007https://conductscience.org/library/papers/17683588PubMed
17585011A double-blind randomized placebo-controlled phase III study of a Pseudomonas aeruginosa flagella vaccine in cystic fibrosis patients.Proc Natl Acad Sci U S A2007https://conductscience.org/library/papers/17585011PubMed
12595463Protection against fatal Pseudomonas aeruginosa pneumonia in mice after nasal immunization with a live, attenuated aroA deletion mutant.Infect Immun2003https://conductscience.org/library/papers/12595463PubMed
9302194Poliovirus-specific immunoglobulin A in persons vaccinated with inactivated poliovirus vaccine in The Netherlands.Clin Diagn Lab Immunol1997https://conductscience.org/library/papers/9302194PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
CD79A973PubTator's text mininghttps://conductscience.org/library/genes/973

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7697276

GET https://conductscience.org/api/papers/v1/7697276/authors